Publication Highlights

JUNE 2022

infection & immunobiology

Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis

december 2021

MS THERAPY

CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in MS

October 2021

infection & immunobiology

COVID-19 vaccine response in people with multiple sclerosis

Summer 2021

Immunogenicity

Immunogenicity of biologics used in the treatment of moderate to severe psoriasis

summer 2021

immunogenicity

Immunogenicity of biologics used in the treatment of inflammatory bowel disease: A review

summer 2021

immunotherapy failure

Anti-drug antibodies to antibody-based therapeutics in multiple sclerosis

July 2020

infection & immunobiology

Mapping the T cell response to COVID-19

june 2020

MS THERAPY

Detecting and predicting neutralization of Alemtuzumab responses in Multiple Sclerosis.